Common aspects of the action of nicotine and other drugs of abuse.
Picciotto
M R
MR
Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06508, USA.
D000818:Animals; D014151:Anti-Anxiety Agents / Q000494:pharmacology; D016739:Behavior, Addictive / Q000503:physiopathology*; D000697:Central Nervous System Stimulants / Q000494:pharmacology; D003071:Cognition / Q000187:drug effects; D006801:Humans; D013287:Illicit Drugs / Q000494:pharmacology*; D009043:Motor Activity / Q000187:drug effects; D009538:Nicotine / Q000494:pharmacology*; D018722:Nicotinic Agonists / Q000494:pharmacology*; D009714:Nucleus Accumbens / Q000187:drug effects / Q000378:metabolism; D011978:Receptors, Nicotinic / Q000737:chemistry / Q000187:drug effects; D012201:Reward; D012651:Self Medication; D013375:Substance Withdrawal Syndrome / Q000503:physiopathology; D019966:Substance-Related Disorders / Q000503:physiopathology; D014029:Tobacco Use Disorder / Q000503:physiopathology*; D017557:Ventral Tegmental Area / Q000187:drug effects / Q000378:metabolism
D014151:Anti-Anxiety Agents; D000697:Central Nervous System Stimulants; D013287:Illicit Drugs; D018722:Nicotinic Agonists; D011978:Receptors, Nicotinic; D009538:Nicotine